Accord BioPharma, Inc., the U.S. arm of Intas Pharmaceuticals, Ltd., has rolled out Imuldosa (ustekinumab-srlf), a match to Stelara (ustekinumab). Sold in ready-to-use syringes and vials, Imuldosa hits the market with the lowest cost
On August 18, 2025, Union Commerce and Industry Minister Piyush Goyal met with leaders from the pharmaceutical industry in New Delhi to discuss how to develop India's pharmaceuticals industry by boosting research and development and better...
Hyderabad-based Aurobindo Pharma has accelerated production at its China facility, which was launched in November last year. The company expects the site will achieve EBITDA goal by Q3 FY26, according to CFO Santhanam Subramanian...
W Health Ventures has strengthened its leadership team with the addition of four seasoned industry leaders. Ashish Singh, Dr. Prakash Patel, and Ajay Sondhi join as Operating Partners, while Mahadevan “Mahad” Narayanamoni comes on board...
The Federation of Pharmaceutical and Allied Products Merchant Exporters (FPME) has called on the central government to establish a Standard Operating Procedure (SOP) allowing for direct airport cargo transfer of imported goods meant for re-export...
Merck a global leader in science and technology is partnered with company builder mantro GmbH (Munich, Germany) to accelerate the establishment of EdiMembre, a Deep-Tech spin-out from Massachusetts, U.S.A., that is poised to disrupt the
The implementation of new policy frameworks, India’s pharmaceutical contract manufacturing industry is emerging as a key player on the global stage,” said Sameer Hiremath, Vice Chairman and Managing Director, Hikal Ltd
According to Saransh Chaudhary, president of Global Critical Care at Venus Remedies and CEO of the Venus Medicine Research Centre, environmental restrictions are desperately needed because antibiotic levels in urban and industrial wastewater around
Xspray Pharma signed a deal with Handa Therapeutics that will give it up to double-digit royalties on Handa's net profits, marking the company's first out-licensing arrangement from its patent portfolio
.jpeg "AN2 Therapeutics Starts First Human Trial of Oral AN2-502998")
AN2 Therapeutics, a company working on new drug tech, shared that it has finished the first round of doses in a test of its new drug, AN2-502998.
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")